1. Home
  2. GKOS vs PCVX Comparison

GKOS vs PCVX Comparison

Compare GKOS & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • PCVX
  • Stock Information
  • Founded
  • GKOS 1998
  • PCVX 2013
  • Country
  • GKOS United States
  • PCVX United States
  • Employees
  • GKOS N/A
  • PCVX N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GKOS Health Care
  • PCVX Health Care
  • Exchange
  • GKOS Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • GKOS 5.1B
  • PCVX 4.5B
  • IPO Year
  • GKOS 2015
  • PCVX 2020
  • Fundamental
  • Price
  • GKOS $89.91
  • PCVX $31.16
  • Analyst Decision
  • GKOS Strong Buy
  • PCVX Strong Buy
  • Analyst Count
  • GKOS 13
  • PCVX 10
  • Target Price
  • GKOS $135.15
  • PCVX $136.50
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • PCVX 2.2M
  • Earning Date
  • GKOS 04-30-2025
  • PCVX 05-07-2025
  • Dividend Yield
  • GKOS N/A
  • PCVX N/A
  • EPS Growth
  • GKOS N/A
  • PCVX N/A
  • EPS
  • GKOS N/A
  • PCVX N/A
  • Revenue
  • GKOS $404,523,000.00
  • PCVX N/A
  • Revenue This Year
  • GKOS $27.84
  • PCVX N/A
  • Revenue Next Year
  • GKOS $27.88
  • PCVX N/A
  • P/E Ratio
  • GKOS N/A
  • PCVX N/A
  • Revenue Growth
  • GKOS 23.92
  • PCVX N/A
  • 52 Week Low
  • GKOS $77.10
  • PCVX $27.66
  • 52 Week High
  • GKOS $163.71
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • PCVX 36.73
  • Support Level
  • GKOS $84.26
  • PCVX $28.09
  • Resistance Level
  • GKOS $92.27
  • PCVX $33.75
  • Average True Range (ATR)
  • GKOS 3.94
  • PCVX 2.54
  • MACD
  • GKOS 0.57
  • PCVX 1.12
  • Stochastic Oscillator
  • GKOS 58.87
  • PCVX 35.61

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: